Examples include miR-125b, a miRNA that directly targets the ETS1 proto-oncogene in breast cancer [86], which exhibits differential expression between primary and metastatic breast tumors [87] and was most recently reported to impact breast cancer chemoresistance in blood serum samples of breast cancer patients [88]. The gene discussed is ETS1; the disease is breast carcinoma.